Vir Biotechnology VIR 深 沪
已收盘 10-31 16:00:00 美东时间
5.96
+0.030
+0.51%
华盛通- 最 高5.98
- 今 开5.87
- 成交量 100.63万股
- 最 低 5.76
- 昨 收 5.93
- 总市值 8.28亿
- 52周最高 14.45
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 4.155
- 委 比 -92.04%
- 总股本 1.39亿
- 历史最高 141.01
- 量 比 0.73
- 振 幅 3.71%
- 历史最低 4.155
- 每 手 1
- 风险率 1.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Medivir Postpones Nomination Committee Appointment Amid Rights Issue
Medivir AB ( ($SE:MVIR) ) has provided an announcement. Medivir AB has announce...
10-29 17:33
Theriva Biologics Addresses Unusual NYSE Trading Activity; Confirms No New Developments Since VIRAGE Trial Data Presentation At ESMO 2025
Theriva™ Biologics (NYSE:TOVX), ("Theriva" or the "Company"), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced today
10-25 02:35
生产经营｜广船国际自主研发双燃料客滚船命名交付
10月23日，由广船国际为全球领先的运输与物流企业MSC地中海航运集团旗下客渡轮运营商Grandi Navi Veloci（GNV）量身打造的一艘现代化大型绿色...
10-24 18:12
Medivir Licenses Remetinostat to Biossil for Global Development
Medivir AB ( ($SE:MVIR) ) just unveiled an update. Medivir AB has entered an ex...
10-23 15:03
LoanCare Enhances its Digital Retention Platform with New Features
Latest enhancements include Paid in Full Monitoring and RateTrak VIRGINIA BEACH, Va., Oct. 15, 2025 /PRNewswire/ -- LoanCare®, a leading national mortgage subservicer, today announced two ne...
10-15 21:30
生产经营｜提前263天 中船澄西交付2025年第20艘新造船
10月10日，中船澄西船舶修造有限公司为中信金融租赁有限公司建造的5号84500吨干散货船较合同期提前263天命名交付。 UPM公司高级副总裁Tomas Wi...
10-11 17:40
Vir Biotechnology Doses First Patient In Part 3 Of Its Phase 1 Trial Evaluating VIR-5500
– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC– Clinical trial builds on
10-10 04:09
Theriva Biologics Cuts 32% Of Workforce In Restructuring To Focus On Cancer Drug Development And Regulatory Strategy; Expects Will Extend Its Cash Runway Into Q2 Of 2026
Item 2.05 Costs Associated with Exit or Disposal Activities. On September 28, 2025, the Board of Directors of Theriva Biologics, Inc. (the "Company") approved a plan to resize and restructure the Company (the
10-03 04:04
迈瑞、美敦力强势押注这一新赛道！
（来源：医疗器械创新网） 商业决策上，企业对业务的重视度，都藏在真金白银的投入里。 美敦力以“五年内向英国投入数千万美元投资”锚定 AI 与机器人...
09-28 17:45
